Sevion Therapeutics
San Diego, US · Delaware corporation
Founders & leadership
MA
Miguel A. de los RiosExecutive
VS
Vaughn SmiderExecutive
JB
Joel BrooksinExecutive
DR
David RectorExecutive
JG
James GrazianoExecutive
Board
PF
Phillip FrostBoard director
SR
Steven RubinBoard director
JB
John BracaBoard director
HW
Harlan W. WaksalBoard director
Reported raises · per SEC filings
Form D private placements$3M disclosed across 1 round · 2015
▶$3MraisedMay 2015 · 14 investors · BiotechnologyRule 506(b)
▶$3MraisedMay 2015 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Miguel A. de los RiosExecutive Officer
- Vaughn SmiderExecutive Officer, Director
- John BracaDirector
- Phillip FrostDirector
- Joel BrooksExecutive Officer
- David RectorExecutive Officer, Director
- Steven RubinDirector
- Harlan W. WaksalDirector
- James GrazianoExecutive Officer
- Offering amount
- $10M
- Amount sold
- $3M
- Minimum investment
- $25K
- Sales commissions
- $190.5K
- Placement agents
- Axiom Capital Management, Inc., Laidlaw & Company (UK), Ltd., Newport Coast Securities, Inc., Palladium Capital Advisors, LLC
- First sale
- May 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Sevion Therapeutics raised?
- Sevion Therapeutics has disclosed $3M raised across 1 round.
- Where is Sevion Therapeutics headquartered?
- Sevion Therapeutics is headquartered in San Diego, US.